Identification of FDA-Approved Drugs with Activity against Stationary Phase <em>Bartonella henselae</em>

Identification of FDA-Approved Drugs with Activity against Stationary Phase <em>Bartonella henselae</em>

<i>Bartonella henselae</i> can cause various infections in humans, ranging from benign and self-limiting diseases to severe and life-threatening diseases as well as persistent infections that are difficult to treat. To develop more effective treatments for persistent Bartonella infection...

Full description

Bibliographic Details
Main Authors: Tingting Li, Jie Feng, Shuzhen Xiao, Wanliang Shi, David Sullivan, Ying Zhang
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Antibiotics
Subjects:
FDA-approved drug library
<i>Bartonella henselae</i>
persisters
stationary phase
antimicrobial activity
Online Access:https://www.mdpi.com/2079-6382/8/2/50

Internet

https://www.mdpi.com/2079-6382/8/2/50

Similar Items